AIDS meeting ends with little hope of breakthrough

“Dr. Julio S. G. Montaner, who heads the AIDS program at the University of British Columbia in
Vancouver, said that H.I.V. therapy was so complex that even experts like him had difficulty keeping track
of therapeutic advances.”

READ THE FULL STORY

Leave a Reply

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025